349 results match your criteria: "Calhoun Cardiology Center.[Affiliation]"
Circ Heart Fail
May 2014
From Pat and Jim Calhoun Cardiology Center, University of Connecticut Medical Center, Farmington, CT (T.Y., J.S., R.Y., J.R., K.D.-K., J.G., B.T.L.); and Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, Bethesda, MD (K.A.J.).
Background: Heart failure (HF), despite continuing progress, remains a leading cause of mortality and morbidity. P2X4 receptors (P2X4R) have emerged as potentially important molecules in regulating cardiac function and as potential targets for HF therapy. Transgenic P2X4R overexpression can protect against HF, but this does not explain the role of native cardiac P2X4R.
View Article and Find Full Text PDFJ Am Soc Hypertens
April 2014
Division of Hypertension & Clinical Pharmacology, Department of Medicine, Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, CT, USA.
Sodium-glucose co-transporter 2 (SGLT2) inhibitors represent a new class of antihyperglycemic agents that block renal sodium and glucose reabsorption and may reduce blood pressure (BP). We assessed the BP lowering ability of these agents using meta-analytic techniques. PubMed, SCOPUS, and Cochrane Central were searched through October 2013.
View Article and Find Full Text PDFJ Gambl Stud
June 2015
Calhoun Cardiology Center, University of Connecticut School of Medicine, MC-3944, 263 Farmington Avenue, Farmington, CT, 06030-3944, USA,
Internet gambling is popular in college students and associated with problem gambling behaviors. This study evaluated Internet gambling in 117 students participating in study evaluating brief interventions to reduce gambling; the brief interventions consisted of minimal advice, motivational enhancement therapy, and cognitive-behavioral therapy (1-4 sessions). Compared to their counterparts who did not gamble via the Internet (n = 60), those who reported recent Internet gambling (n = 57) wagered in greater frequencies and amounts and reported missing school more often and more problems with family and anxiety due to gambling.
View Article and Find Full Text PDFCurr Cardiovasc Risk Rep
October 2013
Division of Hypertension and Clinical Pharmacology, Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, Connecticut.
Sympathetic innervation of the kidneys plays a major role in the pathogenesis of hypertension through modulation of renin secretion, glomerular filtration rate and renal absorption of sodium. Targeted interventions for renal nerve ablation are being developed for treatment of drug resistant hypertension in the USA and rest of the world. Early studies with the use of radiofrequency based renal denervation systems have shown encouraging results with significant reduction of blood pressure in patients inadequately controlled despite nearly maximal drug therapy regimens.
View Article and Find Full Text PDFMany older adults do not meet physical activity recommendations and suffer from health-related complications. Reinforcement interventions can have pronounced effects on promoting behavior change; this study evaluated the efficacy of a reinforcement intervention to enhance walking in older adults. Forty-five sedentary adults with mild to moderate hypertension were randomized to 12-week interventions consisting of pedometers and guidelines to walk 10,000 steps/day or that same intervention with chances to win $1-$100 prizes for meeting recommendations.
View Article and Find Full Text PDFAm Heart J
September 2013
Division of Hypertension and Clinical Pharmacology, Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT. Electronic address:
Chest
September 2013
Division of Hypertension and Clinical Pharmacology, Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT.
N Engl J Med
October 2013
Calhoun Cardiology Center, Department of Medicine, University of Connecticut School of Medicine, 263 Farmington Ave., Farmington, CT 06030-3940, USA.
Background: To assess potentially elevated cardiovascular risk related to new antihyperglycemic drugs in patients with type 2 diabetes, regulatory agencies require a comprehensive evaluation of the cardiovascular safety profile of new antidiabetic therapies. We assessed cardiovascular outcomes with alogliptin, a new inhibitor of dipeptidyl peptidase 4 (DPP-4), as compared with placebo in patients with type 2 diabetes who had had a recent acute coronary syndrome.
Methods: We randomly assigned patients with type 2 diabetes and either an acute myocardial infarction or unstable angina requiring hospitalization within the previous 15 to 90 days to receive alogliptin or placebo in addition to existing antihyperglycemic and cardiovascular drug therapy.
J Am Soc Hypertens
September 2014
Division of Hypertension and Clinical Pharmacology, Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT. Electronic address:
Through modulation of renin secretion, glomerular filtration rate, and renal absorption of sodium, the sympathetic innervation of the kidneys plays an important role in the pathogenesis of hypertension. Renal nerve ablation technology is being developed for treatment of drug-treatment-resistant hypertension worldwide. Preliminary research with the use of radiofrequency-based renal denervation systems have demonstrated encouraging results with significant reduction of blood pressure in patients inadequately controlled despite nearly maximal drug therapy regimens.
View Article and Find Full Text PDFJ Subst Abuse Treat
September 2013
Calhoun Cardiology Center - Behavioral Health, University of Connecticut Health Center, Farmington, CT 06030-3944, USA.
In 2011, the Veterans Administration called for nationwide implementation of contingency management (CM) in its intensive outpatient substance use disorders treatment programs, and this study evaluated the impact of the initial 1 and ½ day training workshops on knowledge and perceptions about CM among 159 clinical leaders from 113 clinics. Workshop attendance significantly increased CM-related knowledge (d=1.88) and changed attendees' perceptions of CM (ds=0.
View Article and Find Full Text PDFAm J Drug Alcohol Abuse
July 2013
Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT, USA.
Background: Multiple types of substance use are associated with HIV risk behaviors, but relatively little research has examined the association between marijuana use and risky sexual activities in treatment-seeking polysubstance abusing patients.
Objectives: This study evaluated the relationship between marijuana use and sexual behaviors in 239 patients with cocaine, opioid or alcohol use disorders who were initiating outpatient substance use treatment.
Methods: Participants completed the HIV Risk Behavior Scale and were classified into one of three groups based on their marijuana use histories: never (n = 66), past but not current use (n = 124) or current use (n = 49).
Curr Heart Fail Rep
September 2013
Pat and Jim Calhoun Cardiology Center, UCONN Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA.
The Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARRESS-HF) trial was a prospective, randomized study comparing ultrafiltration versus pharmacological therapy in the treatment of acute decompensated heart failure (ADHF) complicated by cardiorenal syndrome Bart et al. (N Eng J Med 367:2296-2304, 1). The study found that ultrafiltration was inferior to pharmacological therapy, resulting in a significant increase in serum creatinine and serious adverse events while producing no significant difference in weight loss.
View Article and Find Full Text PDFDrug Alcohol Depend
October 2013
Calhoun Cardiology Center-Behavioral Health, University of Connecticut Health Center MC-3944, 263 Farmington Avenue, Farmington, CT 06030-3944, United States. Electronic address:
Background: Prior studies find no effect of baseline income on response to contingency management (CM) interventions. However, income among substance disordered patients is variable, particularly at treatment entry. This study investigated the impact of during-treatment income, a more proximal estimate of economic resources at the time that CM is in effect, on response to standard treatment or the standard treatment plus CM.
View Article and Find Full Text PDFDiabetes Obes Metab
December 2013
Calhoun Cardiology Center and Department of Medicine, University of Connecticut School of Medicine, Farmington, CT, USA.
Behavioural economics refers to the study of psychological and cognitive factors that relate to decision-making processes. This field is being applied increasingly to health care settings, in which patients receive tangible reinforcers or incentives for meeting objective behavioural criteria consistent with healthy lifestyles. This article reviews the background and efficacy of reinforcement interventions in general, and then as applied to behaviours related to diabetes prevention and management.
View Article and Find Full Text PDFJ Atr Fibrillation
April 2013
Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine.
Atrial fibrillation (AF) is the most common sustained arrhythmia.It is accompanied by both structural and ion channel remodeling which underlie the propensity to perpetuate AF.The prevalence of AF is expected to increase as population ages and as more patients survival myocardial infarction.
View Article and Find Full Text PDFDiabetes Obes Metab
July 2013
Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT 06030, USA.
Aim: As there have been concerns that some classes or agents for the treatment of type 2 diabetes may increase CV risk, we evaluated the cardiovascular profile of the dipeptidyl peptidase-4 inhibitor alogliptin.
Methods: We evaluated the incidence of CV events in patients treated with alogliptin, placebo or comparator antihyperglycaemic drugs in the clinical trial database for alogliptin using the composite major adverse cardiovascular event (MACE) endpoints of CV death, non-fatal myocardial infarction and non-fatal stroke.
Results: The pooled analysis included 4168 patients exposed to alogliptin 12.
J Cardiovasc Pharmacol
June 2013
Pat and Jim Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, CT 06030, USA.
Aim: : The aim of this study was to investigate the therapeutic effect of 2-cyclohexylthio-adenosine 5'-monophosphate (AMP) in mice with heart failure (HF).
Methods: : 2-Cyclohexylthio-AMP was dissolved in phosphate-buffered saline and infused in mice with ischemic HF after permanent left coronary [left anterior descending (LAD)] ligation and in calsequestrin (CSQ) mice with HF. Myocardial function ex vivo was determined in the working heart model.
Curr Top Med Chem
February 2014
Calhoun Cardiology Center, Department of Cell Biology, University of Connecticut Health Center, Farmington, CT 06030, USA.
Cardiac fibrosis is associated with most cardiac diseases. Fibrosis is an accumulation of excessive extracellular matrix proteins (ECM) synthesized by cardiac fibroblasts and myofibroblasts. Fibroblasts are the most prevalent cell type in the heart, comprising 75% of cardiac cells.
View Article and Find Full Text PDFAddiction
March 2013
Calhoun Cardiology Center-Behavioral Health, University of Connecticut Health Center, Farmington, CT, USA.
Chest
September 2013
University Kiel and Lung Clinic Grosshansdorf, members of the German Center for Lung Research, Grosshansdorf, Germany.
Background: Evaluation of cardiovascular safety for new therapies for COPD is important because of a high prevalence of cardiac comorbidities in the COPD population. Hence, we evaluated the effects of roflumilast, a novel oral phosphodiesterase 4 inhibitor developed for the treatment and prevention of COPD exacerbations, on major adverse cardiovascular events (MACEs).
Methods: Intermediate- and long-term placebo-controlled clinical trials of roflumilast in COPD were pooled and assessed for potential cardiovascular events.
Addiction
May 2013
Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, CT, USA.
Aims: Contingency management (CM) uses tangible incentives to systematically reinforce abstinence and is among the most efficacious psychosocial substance abuse treatments. This study assessed the feasibility and initial efficacy of a portable CM procedure designed to address technical limitations for detecting drinking that have prevented using CM for alcohol problems.
Design: Participants received a cellphone, breathalyzer and training on video-recording alcohol breath tests (BrACs) and texting results.
Drug Alcohol Depend
June 2013
Calhoun Cardiology Center - Behavioral Health, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030-3944, USA.
Background: Contingency management (CM) is efficacious for reducing drug use, but it has rarely been applied to patients with severe and persistent mental health problems. This study evaluated the efficacy of CM for reducing cocaine use in psychiatric patients treated at a community mental health center.
Methods: Nineteen cocaine-dependent patients with extensive histories of mental health problems and hospitalizations were randomized to twice weekly urine sample testing with or without CM for 8 weeks.
Circ Heart Fail
November 2012
Pat and Jim Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, CT.
Br J Pharmacol
March 2013
Calhoun Cardiology Center, Department of Cell Biology, University of Connecticut Health Center, Farmington, CT 06030, USA.
Background And Purpose: Transient receptor potential melastatin 7 (TRPM7) is a unique channel kinase which is crucial for various physiological functions. However, the mechanism by which TRPM7 is gated and modulated is not fully understood. To better understand how modulation of TRPM7 may impact biological processes, we investigated if TRPM7 can be regulated by the phospholipids sphingosine (SPH) and sphingosine-1-phosphate (S1P), two potent bioactive sphingolipids that mediate a variety of physiological functions.
View Article and Find Full Text PDFJ Fam Pract
August 2012
Department of Medicine, Division of Hypertension and Clinical Pharmacology, Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, CT, USA.